Description
SWOT ANALYSIS OF ASTRAZENECA
AstraZeneca
Parent Company
AstraZeneca Biopharmaceuticals
Category
Pharmaceutical
Sector
Health Care
Tagline/ Slogan
Health connects us all
AstraZeneca is a global, innovation-driven, integrated USP biopharmaceutical company.
STP
Cardiovascular, neuroscience, gastrointestinal, oncology, infection & Segment respiratory diseases
Healthcare professionals, doctors, hospitals offering treatments for Target Group above mentioned diseases
They are responsible for development of prescription medicines for six Positioning important areas of healthcare such as cancer, infection.
SWOT Analysis
1. Rapid decision making & streamlined due diligence processing 2. Good commercial and R&D presence in emerging markets 3. Active in over 100 countries employing over 60,000 people 4. High investment in R&D with 11,000+ dedicated R&D team 5. Ten products with global sales above 1 billion dollar 6. Product portfolio includes cancer, cardiovascular, gastrointestinal, Strength infection, neuroscience, respiratory and inflammation medicines
1. It was affected by drug shortage crisis as in case of Cefotan 2. Product discontinuation affects the performance Weakness 3. Legal proceedings related to patents and pricing issues affect image
1. It can leverage its strong presence in emerging markets 2. Increasing importance of biosimiler market Opportunity 3. Increasing global ageing population
1. Seroquel their blockbuster drug is facing threat of copycat generic drugs 2. Stringent drug development guidelines Threats 3. Competition coming up with effective drugs
Competition
1. Amgen 2. Genentech 3. Teva Pharmaceuticals Competitors 4. GlaxoSmithKline
doc_638974068.docx
SWOT ANALYSIS OF ASTRAZENECA
AstraZeneca
Parent Company
AstraZeneca Biopharmaceuticals
Category
Pharmaceutical
Sector
Health Care
Tagline/ Slogan
Health connects us all
AstraZeneca is a global, innovation-driven, integrated USP biopharmaceutical company.
STP
Cardiovascular, neuroscience, gastrointestinal, oncology, infection & Segment respiratory diseases
Healthcare professionals, doctors, hospitals offering treatments for Target Group above mentioned diseases
They are responsible for development of prescription medicines for six Positioning important areas of healthcare such as cancer, infection.
SWOT Analysis
1. Rapid decision making & streamlined due diligence processing 2. Good commercial and R&D presence in emerging markets 3. Active in over 100 countries employing over 60,000 people 4. High investment in R&D with 11,000+ dedicated R&D team 5. Ten products with global sales above 1 billion dollar 6. Product portfolio includes cancer, cardiovascular, gastrointestinal, Strength infection, neuroscience, respiratory and inflammation medicines
1. It was affected by drug shortage crisis as in case of Cefotan 2. Product discontinuation affects the performance Weakness 3. Legal proceedings related to patents and pricing issues affect image
1. It can leverage its strong presence in emerging markets 2. Increasing importance of biosimiler market Opportunity 3. Increasing global ageing population
1. Seroquel their blockbuster drug is facing threat of copycat generic drugs 2. Stringent drug development guidelines Threats 3. Competition coming up with effective drugs
Competition
1. Amgen 2. Genentech 3. Teva Pharmaceuticals Competitors 4. GlaxoSmithKline
doc_638974068.docx